Fulgent Genetics, Inc.
(NASDAQ: FLGT)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

14.770 -

+0.090 (+0.61%)
Range 14.660 - 15.050   (2.66%)
Open 14.660
Previous Close 14.680
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 902,380
Value 9,281,418
Remark -
Delayed prices. Updated at 14 Mar 2026 08:15.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis